Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve the Standalone & Consolidated Audited Financial Results for the 4th Quarter and Financial Year Ended on 31st March, 2025.